{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:59:34Z","timestamp":1785581974569,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A 14-year-old American Quarter Horse mare developed a refractory deep surgical site infection following emergency celiotomy for acute right dorsal large colon displacement with 180\u00b0 volvulus. Initial cultures revealed a high-burden polymicrobial infection with\n                    <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">Enterococcus faecium<\/jats:italic>\n                    , associated with delayed healing, and later followed by multidrug-resistant\n                    <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                    , further limiting therapeutic options. Phage therapy was initiated using a customized lytic phage cocktail administered topically on a daily basis over a 35-day period, with cocktail composition guided by daily wound culture results. Phage therapy markedly reduced colony-forming units of targeted pathogens and promoted progressive healing. Wound microbial communities varied during treatment, demonstrating selective pathogen control while preventing residual populations from recolonizing the tissue. By the time of hospital discharge, the wound surface area had decreased by more than 85%, and the body wall had healed without evidence of acute herniation. This case highlights the feasibility, safety, and clinical potential of adaptive phage therapy for managing refractory multidrug-resistant equine wound infections.\n                  <\/jats:p>","DOI":"10.4103\/ijvsm.ijvsm_19_26","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:00:10Z","timestamp":1784106010000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Phage Therapy for a Refractory and Multidrug-resistant Equine Surgical Site Infection"],"prefix":"10.4103","volume":"14","author":[{"given":"Donald","family":"Alverson","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Gary R. Carlson, MD, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Gustafson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Gary R. Carlson, MD, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja F.","family":"Duesterdiec-Zelmer","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Gary R. Carlson, MD, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lacy","family":"Kamm","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Gary R. Carlson, MD, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Danelishvili","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Gary R. Carlson, MD, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cveq.2008.09.002","article-title":"Surgical complications of colic surgery","volume":"24","author":"Dukti","year":"2008","journal-title":"Vet Clin North Am Equine Pract"},{"key":"R2-20260801","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2746\/0425164054529364","article-title":"Survival and complication rates in 300 horses undergoing surgical treatment of colic. Part 2: Short-term complications","volume":"37","author":"Mair","year":"2005","journal-title":"Equine Vet J"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tvjl.2014.01.029","article-title":"Does intraoperative low arterial partial pressure of oxygen increase the risk of surgical site infection following emergency exploratory laparotomy in horses?","volume":"200","author":"Costa-Farr\u00e9","year":"2014","journal-title":"Vet J"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rvsc.2011.07.028","article-title":"Ultrasonographic assessment of standing laparotomy wound healing in dairy cows","volume":"93","author":"Buczinski","year":"2012","journal-title":"Res Vet Sci"},{"key":"R5-20260801","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/vsu.13495","article-title":"Microorganisms associated with incisional infections after gastrointestinal surgery in dogs and cats","volume":"49","author":"Williams","year":"2020","journal-title":"Vet Surg"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/vec.12936","article-title":"Incisional infections associated with ventral midline celiotomy in horses","volume":"30","author":"Shearer","year":"2020","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"R7-20260801","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1939-1676.2012.01024.x","article-title":"Antimicrobial use in horses undergoing colic surgery","volume":"26","author":"Dallap Schaer","year":"2012","journal-title":"J Vet Intern Med"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/ani13091433","article-title":"Current antimicrobial use in horses undergoing exploratory celiotomy: A survey of board-certified equine specialists","volume":"13","author":"Rockow","year":"2023","journal-title":"Animals (Basel)"},{"key":"R9-20260801","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/vms3.382","article-title":"Use of aminoglycoside antibiotics in equine clinical practice;a questionnaire-based study of current use","volume":"7","author":"Redpath","year":"2021","journal-title":"Vet Med Sci"},{"key":"R10-20260801","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/evj.12564","article-title":"Risk factors for surgical site infection following laparotomy: Effect of season and perioperative variables and reporting of bacterial isolates in 287 horses","volume":"49","author":"Isgren","year":"2017","journal-title":"Equine Vet J"},{"key":"R11-20260801","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/vr.101186","article-title":"Comparison of two antimicrobial regimens on the prevalence of incisional infections after colic surgery","volume":"172","author":"Durward-Akhurst","year":"2013","journal-title":"Vet Rec"},{"key":"R12-20260801","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/vde.12958","article-title":"Bacteriophage therapy for challenging bacterial infections: Achievements, limitations and prospects for future clinical use by veterinary dermatologists","volume":"32","author":"Squires","year":"2021","journal-title":"Vet Dermatol"},{"key":"R13-20260801","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"R14-20260801","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1016\/S2468-2667(25)00201-4","article-title":"The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: A cross-country systematic analysis with forecasts to 2050","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"key":"R15-20260801","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/pathogens12060828","article-title":"Topical bacteriophage therapy for staphylococcal superficial pyoderma in horses: A double-blind, placebo-controlled pilot study","volume":"12","author":"Marshall","year":"2023","journal-title":"Pathogens"},{"key":"R16-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rvsc.2007.09.004","article-title":"Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro","volume":"85","author":"Freitag","year":"2008","journal-title":"Res Vet Sci"},{"key":"R17-20260801","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vetsci7010031","article-title":"Antimicrobial activity of a phage mixture and a lactic acid bacterium against Staphylococcus aureus from bovine mastitis","volume":"7","author":"Titze","year":"2020","journal-title":"Vet Sci"},{"key":"R18-20260801","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/antibiotics10040421","article-title":"Phage Therapy in Veterinary Medicine","volume":"10","author":"Loponte","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R19-20260801","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/antibiotics10050559","article-title":"Phage therapy in livestock and companion animals","volume":"10","author":"Ferriol-Gonz\u00e1lez","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R20-20260801","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vetmic.2010.05.014","article-title":"Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before\/after clinical trial","volume":"146","author":"Hawkins","year":"2010","journal-title":"Vet Microbiol"},{"key":"R21-20260801","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mib.2020.01.013","article-title":"Overcoming the challenge of establishing biofilms in vivo: A roadmap for Enterococci","volume":"53","author":"Tan","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"R22-20260801","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/infdis\/jix541","article-title":"Enterococcus faecalis modulates immune activation and slows healing during wound infection","volume":"216","author":"Chong","year":"2017","journal-title":"J Infect Dis"},{"key":"R24-20260801","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chom.2016.09.018","article-title":"Enterococcus faecalis: E coli's siderophore-inducing sidekick","volume":"20","author":"Hughes","year":"2016","journal-title":"Cell Host Microbe"},{"key":"R25-20260801","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.chom.2016.09.004","article-title":"Enterococcal metabolite cues facilitate interspecies niche modulation and polymicrobial infection","volume":"20","author":"Keogh","year":"2016","journal-title":"Cell Host Microbe"},{"key":"R26-20260801","doi-asserted-by":"crossref","first-page":"1753740","DOI":"10.3389\/fcimb.2026.1753740","article-title":"Phage isolation and functional characterization reveal strong antibiofilm activity against Pseudomonas aeruginosa in a cystic fibrosis sputum model","volume":"16","author":"Bowder","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"R27-20260801","doi-asserted-by":"crossref","first-page":"lxaf166","DOI":"10.1093\/jambio\/lxaf166","article-title":"Mucoid phenotype in clinical isolates of Escherichia coli: An underexplored phenomenon","volume":"136","author":"Manna","year":"2025","journal-title":"J Appl Microbiol"},{"key":"R28-20260801","doi-asserted-by":"crossref","first-page":"107571","DOI":"10.1016\/j.ijantimicag.2025.107571","article-title":"Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis","volume":"66","author":"Cesta","year":"2025","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Veterinary Science and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJVSM.IJVSM_19_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:17:36Z","timestamp":1785579456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJVSM.IJVSM_19_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijvsm.ijvsm_19_26","relation":{},"ISSN":["2314-4580","2314-4599"],"issn-type":[{"value":"2314-4580","type":"print"},{"value":"2314-4599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2026-03-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}